Literature DB >> 16089188

Home advantage and the debate about competitive balance in professional sports leagues.

David Forrest1, James Beaumont, John Goddard, Robert Simmons.   

Abstract

A recurrent theme in sports economics is the extent to which overall league attendances will be raised by measures, such as revenue sharing, which aim to improve competitive balance. This debate has ignored the phenomenon of home advantage, which may, however, be important to the extent that, if all teams had equal talent, all matches may then be weighted heavily in favour of the home team. We present an analysis of the relationship between attendance and match-level uncertainty in the English Football League. A simulation from our model indicates that equality of playing talent would in fact lower aggregate attendance. This result is explained by the loss of prospectively the most uncertain games, where weak teams have home advantage over strong teams.

Mesh:

Year:  2005        PMID: 16089188     DOI: 10.1080/02640410400021641

Source DB:  PubMed          Journal:  J Sports Sci        ISSN: 0264-0414            Impact factor:   3.337


  4 in total

1.  Home advantage and mispricing in indoor sports' ghost games: the case of European basketball.

Authors:  Luca De Angelis; J James Reade
Journal:  Ann Oper Res       Date:  2022-09-28       Impact factor: 4.820

2.  Bayesian analysis of home advantage in North American professional sports before and during COVID-19.

Authors:  Nico Higgs; Ian Stavness
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

3.  Estimating the change in soccer's home advantage during the Covid-19 pandemic using bivariate Poisson regression.

Authors:  Luke S Benz; Michael J Lopez
Journal:  Adv Stat Anal       Date:  2021-07-27       Impact factor: 1.281

4.  Effects of expertise on football betting.

Authors:  Yasser Khazaal; Anne Chatton; Joël Billieux; Lucio Bizzini; Grégoire Monney; Emmanuelle Fresard; Gabriel Thorens; Guido Bondolfi; Nady El-Guebaly; Daniele Zullino; Riaz Khan
Journal:  Subst Abuse Treat Prev Policy       Date:  2012-05-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.